AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/124
QUANTITATIVE HEPATITIS-B VIRUS-DNA ASSESSMENT BY THE LIMITING-DILUTION POLYMERASE-CHAIN-REACTION IN CHRONIC HEPATITIS-B PATIENTS - EVIDENCEOF CONTINUING VIRAL SUPPRESSION WITH LONGER DURATION AND HIGHER DOSE OF LAMIVUDINE THERAPY
Authors: HONKOOP P DEMAN RA NIESTERS HGM MAIN J NEVENS F THOMAS HC FEVERY J TYRRELL DL SCHALM SW
Citation: P. Honkoop et al., QUANTITATIVE HEPATITIS-B VIRUS-DNA ASSESSMENT BY THE LIMITING-DILUTION POLYMERASE-CHAIN-REACTION IN CHRONIC HEPATITIS-B PATIENTS - EVIDENCEOF CONTINUING VIRAL SUPPRESSION WITH LONGER DURATION AND HIGHER DOSE OF LAMIVUDINE THERAPY, Journal of viral hepatitis, 5(5), 1998, pp. 307-312
TRANSMISSION OF HEPATITIS-B VIRUS AMONG HEART-TRANSPLANT RECIPIENTS DURING ENDOMYOCARDIAL BIOPSY PROCEDURES
Authors: OSTERHAUS ADME VOS MC BALK AHMM DEMAN RA MOUTON JW ROTHBARTH PH SCHALM SW TOMAELLO AM NIESTERS HGM VERBRUGH HA
Citation: Adme. Osterhaus et al., TRANSMISSION OF HEPATITIS-B VIRUS AMONG HEART-TRANSPLANT RECIPIENTS DURING ENDOMYOCARDIAL BIOPSY PROCEDURES, The Journal of heart and lung transplantation, 17(2), 1998, pp. 158-166
ENDOSCOPIC SCLEROTHERAPY FOR BLEEDING ESOPHAGOGASTRIC VARICES SECONDARY TO EXTRAHEPATIC PORTAL-VEIN OBSTRUCTION IN AN ADULT CAUCASIAN POPULATION
Authors: VLEGGAAR FP VANBUUREN HR SCHALM SW
Citation: Fp. Vleggaar et al., ENDOSCOPIC SCLEROTHERAPY FOR BLEEDING ESOPHAGOGASTRIC VARICES SECONDARY TO EXTRAHEPATIC PORTAL-VEIN OBSTRUCTION IN AN ADULT CAUCASIAN POPULATION, European journal of gastroenterology & hepatology, 10(1), 1998, pp. 81-85
INCREASED INTRAGRAFT IL-15 MESSENGER-RNA EXPRESSION AFTER LIVER-TRANSPLANTATION
Authors: BAAN CC NIESTERS HGM METSELAAR HJ MOL WM LOONEN EHM ZONDERVAN PE TILANUS HW IJZERMANS JMN SCHALM SW WEIMAR W
Citation: Cc. Baan et al., INCREASED INTRAGRAFT IL-15 MESSENGER-RNA EXPRESSION AFTER LIVER-TRANSPLANTATION, Clinical transplantation, 12(3), 1998, pp. 212-218
RELAPSE AFTER INTERFERON FOR CHRONIC HEPATITIS-C - A METAANALYSIS OF INDIVIDUAL DATA ON RETREATMENT
Authors: CAMMA C GIUNTA M CRAXI A SCHALM SW
Citation: C. Camma et al., RELAPSE AFTER INTERFERON FOR CHRONIC HEPATITIS-C - A METAANALYSIS OF INDIVIDUAL DATA ON RETREATMENT, Hepatology, 28(4), 1998, pp. 491-491
VIRAL KINETICS OF THE HEPATITIS-C VIRUS IN PATIENTS TREATED WITH HIGH-DOSE DAILY COMBINATION THERAPY
Authors: BEKKERINQ FC BROUWER JT NIESTERS HGM SIEBELINK CHJ SCHALM SW
Citation: Fc. Bekkerinq et al., VIRAL KINETICS OF THE HEPATITIS-C VIRUS IN PATIENTS TREATED WITH HIGH-DOSE DAILY COMBINATION THERAPY, Hepatology, 28(4), 1998, pp. 504-504
HEPATITIS-C VIRUS GENOTYPE AND CLINICAL OUTCOME OF COMPENSATED CIRRHOSIS TYPE-C
Authors: FATTOVICH G RIBERO ML PANTALENA M DIODATI G ALMASIO P NEVENS F TREMOLADA F DEGOS F RAI GRJ SOLINAS A MURA D TOCCO A REALDI G CORROCHER R SCHALM SW TAGGER A
Citation: G. Fattovich et al., HEPATITIS-C VIRUS GENOTYPE AND CLINICAL OUTCOME OF COMPENSATED CIRRHOSIS TYPE-C, Hepatology, 28(4), 1998, pp. 981-981
HEPATITIS-B VIRAL DYNAMICS DURING 4 WEEKS OF LAMIVUDINE - 150 MG VERSUS 600 MG
Authors: WOLTERS LMM NIESTERS HGM SCHALM SW SCHMIDT JM ZEUZEM S DEMAN RA
Citation: Lmm. Wolters et al., HEPATITIS-B VIRAL DYNAMICS DURING 4 WEEKS OF LAMIVUDINE - 150 MG VERSUS 600 MG, Hepatology, 28(4), 1998, pp. 1300-1300
TREATMENT WITH BUDESONIDE OR PREDNISONE IN COMBINATION WITH URSODEOXYCHOLIC ACID (UDCA) IN PRIMARY SCLEROSING CHOLANGITIS (PSC) - A RANDOMIZED CONTROLLED PILOT-STUDY
Authors: VLEGGAAR FP VANHOOGSTRATEN HJF BOLAND GJ VANSTEENBERGEN W VANHATTUM J HENEGOUWEN GPV SCHALM SW VANBUUREN HR
Citation: Fp. Vleggaar et al., TREATMENT WITH BUDESONIDE OR PREDNISONE IN COMBINATION WITH URSODEOXYCHOLIC ACID (UDCA) IN PRIMARY SCLEROSING CHOLANGITIS (PSC) - A RANDOMIZED CONTROLLED PILOT-STUDY, Hepatology, 28(4), 1998, pp. 1938-1938
SUBCLINICAL HEPATIC-ENCEPHALOPATHY IMPAIRS DAILY FUNCTIONING
Authors: GROENEWEG M QUERO JC DEBRUIJN I HARTMANN IJC ESSINKBOT ML HOP WCJ SCHALM SW
Citation: M. Groeneweg et al., SUBCLINICAL HEPATIC-ENCEPHALOPATHY IMPAIRS DAILY FUNCTIONING, Hepatology, 28(1), 1998, pp. 45-49
REVIEW ARTICLE - GLYCYRRHIZIN AS A POTENTIAL TREATMENT FOR CHRONIC HEPATITIS-C
Authors: VANROSSUM TGJ VULTO AG DEMAN RA BROUWER JT SCHALM SW
Citation: Tgj. Vanrossum et al., REVIEW ARTICLE - GLYCYRRHIZIN AS A POTENTIAL TREATMENT FOR CHRONIC HEPATITIS-C, Alimentary pharmacology & therapeutics, 12(3), 1998, pp. 199-205
A RANDOMIZED TRIAL IN PRIMARY BILIARY-CIRRHOSIS COMPARING URSODEOXYCHOLIC ACID IN DAILY DOSES OF EITHER 10 MG KG OR 20 MG/KG/
Authors: VANHOOGSTRATEN HJF DESMET MBM RENOOIJ W BREED JGS ENGELS LGJB DENOUDENMULLER JW RIJK MCM SMIT AM ZWERTBROEK R HOP WCJ HENEGOUWEN GPV SCHALM SW VANBUUREN HR
Citation: Hjf. Vanhoogstraten et al., A RANDOMIZED TRIAL IN PRIMARY BILIARY-CIRRHOSIS COMPARING URSODEOXYCHOLIC ACID IN DAILY DOSES OF EITHER 10 MG KG OR 20 MG/KG/, Alimentary pharmacology & therapeutics, 12(10), 1998, pp. 965-971
TRIPLE THERAPY WITH URSODEOXYCHOLIC ACID, PREDNISONE AND AZATHIOPRINEIN PRIMARY BILIARY-CIRRHOSIS - A 1-YEAR RANDOMIZED, PLACEBO-CONTROLLED STUDY
Authors: WOLFHAGEN FHJ VANHOOGSTRATEN HJF VANBUUREN HR VANBERGEHENEGOUWEN GP TENKATE FJW HOP WCJ VANDERHOEK EW KERBERT MJ VANLIJF HH DENOUDEN JW SMIT AM DEVRIES RA VANZANTEN RAA SCHALM SW
Citation: Fhj. Wolfhagen et al., TRIPLE THERAPY WITH URSODEOXYCHOLIC ACID, PREDNISONE AND AZATHIOPRINEIN PRIMARY BILIARY-CIRRHOSIS - A 1-YEAR RANDOMIZED, PLACEBO-CONTROLLED STUDY, Journal of hepatology, 29(5), 1998, pp. 736-742
URSODEOXYCHOLIC ACID THERAPY FOR PRIMARY SCLEROSING CHOLANGITIS - RESULTS OF A 2-YEAR RANDOMIZED CONTROLLED TRIAL TO EVALUATE SINGLE VERSUSMULTIPLE DAILY DOSES
Authors: VANHOOGSTRATEN HJF WOLFHAGEN FHJ VANDEMEEBERG PC KUIPER H NIX GAJJ BECX MCJM HOEK AC VANHOUTE DPF RIJK MCM SALEMANS JMJI SCHERPENISSE J SCHRIJVER M SMIT AM SPOELSTRA P STADHOUDERS PHGM TAN TG HOP WCJ TENKATE FJW VANBERGEHENEGOUWEN GP SCHALM SW VANBUUREN HR
Citation: Hjf. Vanhoogstraten et al., URSODEOXYCHOLIC ACID THERAPY FOR PRIMARY SCLEROSING CHOLANGITIS - RESULTS OF A 2-YEAR RANDOMIZED CONTROLLED TRIAL TO EVALUATE SINGLE VERSUSMULTIPLE DAILY DOSES, Journal of hepatology, 29(3), 1998, pp. 417-423
CLINICAL IMPACT OF LAMIVUDINE RESISTANCE IN CHRONIC HEPATITIS-B
Authors: HONKOOP P DEMAN RA NIESTERS HGM SCHALM SW
Citation: P. Honkoop et al., CLINICAL IMPACT OF LAMIVUDINE RESISTANCE IN CHRONIC HEPATITIS-B, Journal of hepatology, 29(3), 1998, pp. 510-511
EFFICACY OF INTERFERON DOSE AND PREDICTION OF RESPONSE IN CHRONIC HEPATITIS-C - BENELUX STUDY IN 336 PATIENTS
Authors: BROUWER JT NEVENS F KLETER B ELEWAUT A ADLER M BRENARD R CHAMULEAU RAFM MICHIELSEN PP PIROTTE J HAUTEKEETE ML WEBER J BOURGEOIS N HANSEN BE BRONKHORST CM TENKATE FJW HEIJTINK RA FEVERY J SCHALM SW
Citation: Jt. Brouwer et al., EFFICACY OF INTERFERON DOSE AND PREDICTION OF RESPONSE IN CHRONIC HEPATITIS-C - BENELUX STUDY IN 336 PATIENTS, Journal of hepatology, 28(6), 1998, pp. 951-959
ULTRARAPID HEPATITIS-C VIRUS CLEARANCE BY DAILY HIGH-DOSE INTERFERON IN NONRESPONDERS TO STANDARD THERAPY
Authors: BEKKERING FC BROUWER JT LEROUXROELS G VANVLIERBERGHE H ELEWAUT A SCHALM SW
Citation: Fc. Bekkering et al., ULTRARAPID HEPATITIS-C VIRUS CLEARANCE BY DAILY HIGH-DOSE INTERFERON IN NONRESPONDERS TO STANDARD THERAPY, Journal of hepatology, 28(6), 1998, pp. 960-964
HEPATITIS-C VIRUS GENOTYPES - EPIDEMIOLOGIC AND CLINICAL ASSOCIATIONS
Authors: KLETER B BROUWER JT NEVENS F VANDOORN LJ ELEWAUT A VERSIECK J MICHIELSEN PP HAUTEKEETE ML CHAMULEAU RAFM BRENARD R BOURGEOIS N ADLER M QUINT WGV BRONKHORST CM HEIJTINK RA HOP WJC FEVERY J SCHALM SW
Citation: B. Kleter et al., HEPATITIS-C VIRUS GENOTYPES - EPIDEMIOLOGIC AND CLINICAL ASSOCIATIONS, Liver, 18(1), 1998, pp. 32-38
IDENTIFICATION OF MORE THAN ONE MUTATION IN THE HEPATITIS-B VIRUS POLYMERASE GENE ARISING DURING PROLONGED LAMIVUDINE TREATMENT
Authors: NIESTERS HGM HONKOOP P HAAGSMA EB DEMAN RA SCHALM SW OSTERHAUS ADME
Citation: Hgm. Niesters et al., IDENTIFICATION OF MORE THAN ONE MUTATION IN THE HEPATITIS-B VIRUS POLYMERASE GENE ARISING DURING PROLONGED LAMIVUDINE TREATMENT, The Journal of infectious diseases, 177(5), 1998, pp. 1382-1385
DELAYED CLEARANCE OF SERUM HBSAG IN COMPENSATED CIRRHOSIS-B - RELATION TO INTERFERON-ALPHA THERAPY AND DISEASE PROGNOSIS
Authors: FATTOVICH G GIUSTINA G SANCHEZTAPIAS J QUERO C MAS A OLIVOTTO PG SOLINAS A ALMASIO P HADZIYANNIS S DEGOS F DEMOURA MC KROGSGAARD K PANTALENA M REALDI G CORROCHER R SCHALM SW CRAXI A DELAROCQUE E SAVVAS S COSSU PA TOCCO A OLSEN JF CHRISTENSEN E ROCHA P
Citation: G. Fattovich et al., DELAYED CLEARANCE OF SERUM HBSAG IN COMPENSATED CIRRHOSIS-B - RELATION TO INTERFERON-ALPHA THERAPY AND DISEASE PROGNOSIS, The American journal of gastroenterology, 93(6), 1998, pp. 896-900
SOLUBLE INTERCELLULAR-ADHESION MOLECULE-1 IN PRIMARY BILIARY-CIRRHOSIS - EFFECT OF URSODEOXYCHOLIC ACID AND IMMUNOSUPPRESSIVE THERAPY
Authors: LIM AG WOLFHAGEN FHJ VERMA A VANBUUREN HR JAZRAWI RP LEVY JH NORTHFIELD TC SCHALM SW
Citation: Ag. Lim et al., SOLUBLE INTERCELLULAR-ADHESION MOLECULE-1 IN PRIMARY BILIARY-CIRRHOSIS - EFFECT OF URSODEOXYCHOLIC ACID AND IMMUNOSUPPRESSIVE THERAPY, European journal of gastroenterology & hepatology, 9(2), 1997, pp. 155-161
HEPATITIS-C ANNO 1997
Authors: SCHALM SW
Citation: Sw. Schalm, HEPATITIS-C ANNO 1997, Netherlands journal of medicine, 51(6), 1997, pp. 195-197
HEPATITIS-C - VIRAL KINETICS
Authors: BEKKERING FC BROUWER JT SCHALM SW ELEWAUT A
Citation: Fc. Bekkering et al., HEPATITIS-C - VIRAL KINETICS, Hepatology, 26(6), 1997, pp. 1691-1692
LONG-TERM OUTCOME OF HEPATITIS-B E-ANTIGEN-POSITIVE PATIENTS WITH COMPENSATED CIRRHOSIS TREATED WITH INTERFERON-ALFA
Authors: FATTOVICH G GIUSTINA G REALDI G CORROCHER R SCHALM SW ALMASIO P DEGOS F OLIVOTTO PG SANCHEZTAPIAS J HADZIYANNIS S SOLINAS A KROGSGAARD K DEMOURA MC
Citation: G. Fattovich et al., LONG-TERM OUTCOME OF HEPATITIS-B E-ANTIGEN-POSITIVE PATIENTS WITH COMPENSATED CIRRHOSIS TREATED WITH INTERFERON-ALFA, Hepatology, 26(5), 1997, pp. 1338-1342
DYNAMICS OF HEPATITIS-B VIRUS-INFECTION IN-VIVO
Authors: ZEUZEM S DEMAN RA HONKOOP P ROTH WK SCHALM SW SCHMIDT JM
Citation: S. Zeuzem et al., DYNAMICS OF HEPATITIS-B VIRUS-INFECTION IN-VIVO, Hepatology, 26(4), 1997, pp. 752-752
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>